Jonathan Singer, MD


Dr. Jonathan Singer is a pulmonologist and critical care specialist in the Lung Transplant Program who treats patients with advanced lung disease, before and after lung transplants. He treats conditions such as idiopathic pulmonary fibrosis, interstitial lung disease (ILD), connective-tissue disease associated with ILD, hypersensitivity pneumonitis, cystic fibrosis and chronic obstructive pulmonary disease.

In his research, he studies outcomes in lung transplantation and how lung transplants improve function, reduce disability and improve health-related quality of life. A second area of research is to identify pre-transplant risk factors associated with important outcomes following lung transplantation.

Singer earned a medical degree and Master of Science degree in the joint UC Berkeley and UCSF program. He completed a residency at UCSF in internal medicine and fellowships in pulmonary and critical care medicine and lung and heart-lung transplantation, both at UCSF.

He is a member of the American Thoracic Society, the International Society for Heart and Lung Transplantation, American College of Chest Physicians and European Respiratory Society. Singer is board-certified in internal medicine, pulmonary medicine and critical care medicine. He is a clinical instructor of medicine at UCSF.


Lung Transplant Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Conditions & Treatments

Board Certification

Critical Care Medicine, American Board of Internal Medicine
Pulmonary Disease, American Board of Internal Medicine

Academic Title

Associate Professor

More about Jonathan Singer


UCSF Medical Center School of Medicine 2004


UC San Francisco Medical Center 2007


UC San Francisco Medical Center 2010

Selected Research and Publications

  1. Kozuch JM, Feist A, Yung G, Awdishu L, Hays S, Singer JP, Florez R. Low Dose Posaconazole Delayed Release Tablets for Fungal Prophylaxis in Lung Transplant Recipients. Clin Transplant. 2018 May 28; e13300.
  2. Singer JP, Soong A, Bruun A, Bracha A, Chin G, Hays SR, Kukreja J, Rigler J, Golden JA, Greenland JR, Garvey C. A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: A pilot study. Clin Transplant. 2018 May 09; e13274.
  3. Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, Kendall K, Young QR, Abbey SE, Butt Z, Crone CC, De Geest S, Doligalski CT, Kugler C, McDonald L, Ohler L, Painter L, Petty MG, Robson D, Schlöglhofer T, Schneekloth TD, Singer JP, Smith PJ, Spaderna H, Teuteberg JJ, Yusen RD, Zimbrean PC. The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. J Heart Lung Transplant. 2018 Apr 27.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.